Abstract
1 Not only has insomnia become much more frequent in the last hundred years but its causes have also changed considerably.
2 In the treatment of insomnia, benzodiazepines—because of their additional anxiolytic effect—offer substantial advantages over other sleep-inducing agents.
3 The residual fraction—the quotient of plasma concentration at 12 h after drug intake to maximum plasma concentration—makes it possible to differentiate between the benzodiazepines according to their suitability as anxiolytics or hypnotics.
4 Midazolam has the lowest residual fraction of all known benzodiazepines and thus, administered in the appropriate dosage, also has the shortest duration of activity.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Amrein R., Eckert M. Zur Pharmakokinetik von Schlafmitteln. ZFA (Stuttgart) 1980 Jun 10;56(16):1163–1171. [PubMed] [Google Scholar]
- Boxenbaum H. G., Posmanter H. N., Macasieb T., Geitner K. A., Weinfeld R. E., Moore J. D., Darragh A., O'Kelly D. A., Weissman L., Kaplan S. A. Pharmacokinetics of flunitrazepam following single- and multiple-dose oral administration to healthy human subjects. J Pharmacokinet Biopharm. 1978 Aug;6(4):283–293. doi: 10.1007/BF01060092. [DOI] [PubMed] [Google Scholar]
- Cano J. P., Soliva M., Hartmann D., Ziegler W. H., Amrein R. Bioavailability from various galenic formulations of flunitrazepam. Arzneimittelforschung. 1977;27(12):2383–2388. [PubMed] [Google Scholar]
- Heizmann P., Eckert M., Ziegler W. H. Pharmacokinetics and bioavailability of midazolam in man. Br J Clin Pharmacol. 1983;16 (Suppl 1):43S–49S. doi: 10.1111/j.1365-2125.1983.tb02270.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klotz U., Antonin K. H., Brügel H., Bieck P. R. Disposition of diazepam and its major metabolite desmethyldiazepam in patients with liver disease. Clin Pharmacol Ther. 1977 Apr;21(4):430–436. doi: 10.1002/cpt1977214430. [DOI] [PubMed] [Google Scholar]
- Knowles J. A., Ruelius H. W. Absorption and excretion of 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one (oxazepam) in humans. Determination of the drug by gas-liquid chromatography with electron capture detection. Arzneimittelforschung. 1972 Apr;22(4):687–692. [PubMed] [Google Scholar]